Cargando…

Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant

Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat st...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibori, Kinga, Orosz, Gabriella, Zámbó, Veronika, Szelényi, Péter, Sarnyai, Farkas, Tamási, Viola, Rónai, Zsolt, Mátyási, Judit, Tóth, Blanka, Csala, Miklós, Kereszturi, Éva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181825/
https://www.ncbi.nlm.nih.gov/pubmed/35682900
http://dx.doi.org/10.3390/ijms23116221
_version_ 1784723879435960320
author Tibori, Kinga
Orosz, Gabriella
Zámbó, Veronika
Szelényi, Péter
Sarnyai, Farkas
Tamási, Viola
Rónai, Zsolt
Mátyási, Judit
Tóth, Blanka
Csala, Miklós
Kereszturi, Éva
author_facet Tibori, Kinga
Orosz, Gabriella
Zámbó, Veronika
Szelényi, Péter
Sarnyai, Farkas
Tamási, Viola
Rónai, Zsolt
Mátyási, Judit
Tóth, Blanka
Csala, Miklós
Kereszturi, Éva
author_sort Tibori, Kinga
collection PubMed
description Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat storage and contributing to cellular defense against saturated fatty acid toxicity. Recent studies show that increased activity or over-expression of SCD1 is one of the contributing factors for type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of the common missense rs2234970 (M224L) polymorphism on SCD1 function in transfected cells. We found a higher expression of the minor Leu224 variant, which can be attributed to a combination of mRNA and protein stabilization. The latter was further enhanced by various fatty acids. The increased level of Leu224 variant resulted in an elevated unsaturated: saturated fatty acid ratio, due to higher oleate and palmitoleate contents. Accumulation of Leu224 variant was found in a T2DM patient group, however, the difference was statistically not significant. In conclusion, the minor variant of rs2234970 polymorphism might contribute to the development of obesity-related metabolic disorders, including T2DM, through an increased intracellular level of SCD1.
format Online
Article
Text
id pubmed-9181825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91818252022-06-10 Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant Tibori, Kinga Orosz, Gabriella Zámbó, Veronika Szelényi, Péter Sarnyai, Farkas Tamási, Viola Rónai, Zsolt Mátyási, Judit Tóth, Blanka Csala, Miklós Kereszturi, Éva Int J Mol Sci Article Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat storage and contributing to cellular defense against saturated fatty acid toxicity. Recent studies show that increased activity or over-expression of SCD1 is one of the contributing factors for type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of the common missense rs2234970 (M224L) polymorphism on SCD1 function in transfected cells. We found a higher expression of the minor Leu224 variant, which can be attributed to a combination of mRNA and protein stabilization. The latter was further enhanced by various fatty acids. The increased level of Leu224 variant resulted in an elevated unsaturated: saturated fatty acid ratio, due to higher oleate and palmitoleate contents. Accumulation of Leu224 variant was found in a T2DM patient group, however, the difference was statistically not significant. In conclusion, the minor variant of rs2234970 polymorphism might contribute to the development of obesity-related metabolic disorders, including T2DM, through an increased intracellular level of SCD1. MDPI 2022-06-02 /pmc/articles/PMC9181825/ /pubmed/35682900 http://dx.doi.org/10.3390/ijms23116221 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tibori, Kinga
Orosz, Gabriella
Zámbó, Veronika
Szelényi, Péter
Sarnyai, Farkas
Tamási, Viola
Rónai, Zsolt
Mátyási, Judit
Tóth, Blanka
Csala, Miklós
Kereszturi, Éva
Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
title Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
title_full Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
title_fullStr Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
title_full_unstemmed Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
title_short Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
title_sort molecular mechanisms underlying the elevated expression of a potentially type 2 diabetes mellitus associated scd1 variant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181825/
https://www.ncbi.nlm.nih.gov/pubmed/35682900
http://dx.doi.org/10.3390/ijms23116221
work_keys_str_mv AT tiborikinga molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT oroszgabriella molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT zamboveronika molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT szelenyipeter molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT sarnyaifarkas molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT tamasiviola molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT ronaizsolt molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT matyasijudit molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT tothblanka molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT csalamiklos molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant
AT kereszturieva molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant